Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

7.115 +0.255 (+3.72%)
Streaming Delayed Price Updated: 11:37 AM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
31 32 Next >
Psychedelic Stock Gainers And Losers From December 23, 2022 ↗
 
Via Benzinga
Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 21, 2022 ↗
 
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 19, 2022 ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD ↗
The 6 largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances are down again this week. 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 13, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 9, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 7, 2022 ↗
 
Via Benzinga
News headline image
EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill ↗
Part two of a three-part series. Previous story: Standardized Ayahuasca Pill Is Officially Here, Feast Yourself With The Exclusive Details & Insights 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 ↗
 
Via Benzinga
News headline image
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More ↗
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From December 12, 2022 ↗
 
Via Benzinga
News headline image
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far ↗
Mental health care company COMPASS Pathways plc (NASDAQ: CMPS) has announced positive data demonstrating the potential of its proprietary synthetic psilocybin compound COMP360 in treating depression... 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD ↗
Today's article highlights the performance of the largest psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of ten (10) different psychedelic substances. 
Via Talk Markets
News headline image
Colorado's Psychedelics Legal Scenario: Insurance & State Aid, Advisory Board And Local Regulations ↗
Part three of three-part series.  See previous stories:  Colorado's New Psychedelics Regulations: Co-Author Of The Bill Replies To Concerns 
Via Benzinga
News headline image
Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments ↗
(Part four of a four-part series) See previous stories:  
Via Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD ↗
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From December 2, 2022 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From December 1, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022 ↗
 
Via Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More ↗
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon 
Via Benzinga
News headline image
3 Big Trends Shaking Up Psychedelic Stocks ↗
Major positive shifts are happening, but the field faces new headwinds too. 
Via The Motley Fool
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.